JANX - Janux Therapeutics - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

JANX is currently covered by 8 analysts with an average price target of $41.59. This is a potential upside of $38.86 (152.98%) from yesterday's end of day stock price of $16.44.

Janux Therapeutics's activity chart (see below) currently has 51 price targets and 60 ratings on display. The stock rating distribution of JANX is 100% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 20.13% with an average time for these price targets to be met of 108.29 days.

Highest price target for JANX is $68, Lowest price target is $12, average price target is $41.59.

Most recent stock forecast was given by from PIPER SANDLER on 08-May-2026. First documented stock forecast 06-Jul-2021.

Best performing analysts who are covering JANX - Janux Therapeutics:

Swayampakula Ramakanth Robert Driscoll Geoff Meacham Kelsey Goodwin

Currently out of the existing stock ratings of JANX, 12 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 19-Aug-2025

$26

$11.06 (74.03%)

$30

4 months 8 days ago
(08-May-2026)

0/3 (0%)

$11.82 (83.36%)

Buy Since 06-Apr-2023

$36

$21.06 (140.96%)

$74

4 months 8 days ago
(08-May-2026)

5/8 (62.5%)

$21.82 (153.88%)

232

Buy Since 06-Sep-2024

$68

$53.06 (355.15%)

6 months 20 days ago
(27-Feb-2026)

0/5 (0%)

$54.39 (399.63%)

Buy Since 06-Jul-2021

6 months 20 days ago
(27-Feb-2026)

1/8 (12.5%)

$174.04 (670.42%)

966

Buy Since 20-Mar-2024

$12

$-2.94 (-19.68%)

$32

7 months 27 days ago
(20-Jan-2026)

1/4 (25%)

$-1.15 (-8.75%)

43

Show more analysts

Please expand the browser size to see the chart

What is JANX (Janux Therapeutics) average time for price targets to be met?

On average it took 108 days for the stock forecasts to be reached, with an average price target met ratio of 20.13%.

Which analyst most recently updated their price target on JANX (Janux Therapeutics)?

Which analyst has the most public recommendations on JANX (Janux Therapeutics)?

has 0 price targets and 0 ratings on JANX

Which analyst is the currently most bullish on JANX (Janux Therapeutics)?

Karina Rabayeva with the highest potential upside of $85.06

Which analyst is the currently most reserved on JANX (Janux Therapeutics)?

Kaveri Pohlman with the lowest potential downside of -$5.1

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?